Instrument Integration for Dissolution Testing
Shimadzu and Hanson Research partner on pharmaceutical testing instrument integration.
Shimadzu and Hanson Research have announced a strategic partnership to integrate Hanson’s semi-automated Vision dissolution platform with Shimadzu’s UV-1800 to create an automated on-line system designed to meet demand for automation efficiencies, better reporting and data integrity, audit-proof security compliance, and simplification of complex processes.
In addition, Hanson will introduce a semi-automated integration of the company's Vision AutoPlus dissolution autosampler to Shimadzu’s HPLC product for dissolution labs that require an HPLC analytical finish.
The Shimadzu and Hanson-integrated products were launched at the American Association of Pharmaceutical Scientists (AAPS) annual meeting and expo in Orlando, FL.
Source: Hanson Research
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
